RestorGenex

36 articles with RestorGenex

• RestorGenex and Diffusion Pharma Merge to Form Wholly-Owned Oncology Subsidiary

  12/28/2015

• RestorGenex Reports Third Quarter 2015 Financial Results

  11/13/2015

• RestorGenex To Present At Two Upcoming Growth Conferences

  10/6/2015

• RestorGenex To Present At Rodman & Renshaw Global Investment Conference

  9/3/2015

• RestorGenex Reports Financial Results

  8/12/2015

• RestorGenex Announces Positive 3-D Cancer Cell Culture Data For RES-529, A TORC1/TORC2 Inhibitor

  7/14/2015

• RestorGenex Announces Prostate Cancer Data On RES-529, A Dual TORC1/TORC2 Inhibitor

  6/23/2015

• RestorGenex Announces Presentation Of Prostate Cancer Data On RES-529, A Dual TORC1/TORC2 Inhibitor

  6/19/2015

• RestorGenex Announces Stockholder Approval Of Reincorporation In Delaware

  6/18/2015

• RestorGenex CEO Featured In Equities.com Interview

  6/16/2015

• RestorGenex To Present At The Small-Cap Stars Spring Conference 2015 At Convene In Times Square New York On June 10

  6/4/2015

• RestorGenex To Present At The Annual LD Micro Invitational Conference

  6/2/2015

• RestorGenex Announces Data On The Effect Of RES-529 In Pulmonary Fibrosis Models

  5/21/2015

• RestorGenex To Present At Two Investor Conferences

  5/20/2015

• RestorGenex Reports First Quarter 2015 Financial Results

  5/11/2015

• RestorGenex Issues Annual Letter To Stockholders

  4/23/2015

• RestorGenex Reports Corporate Highlights And Financial Results For 2014

  4/6/2015

• RestorGenex CEO Featured In Equities.com Interview

  3/24/2015

• RestorGenex To Present At The Future Leaders In The Biotech Industry Conference

  3/18/2015

• RestorGenex To Present At The 27th Annual ROTH Conference

  3/5/2015